Nerve Grafting Technique to Preserve Erectile Function in Patients Undergoing Robotic Assisted Radical Prostatectomy
Prostate Cancer | Erectile DysfunctionThe investigator proposing a single arm prospective pilot trial evaluating the safety and the 1-year erectile recovery outcomes of patients undergoing Nerve Restoring (NR) Robotically assisted laparoscopic radical prostatectomy (RALP). During this study a total of 10 patients who are undergoing robotic prostatectomy will have their surgery performed utilizing a novel technique, NR-RALP, which incorporates a genitofemoral (GFN) nerve graft designed to try to improve the erectile function and recovery of men undergoing standard of care robotic prostatectomy while minimizing additional morbidity of the procedure
null
Participation Requirements
-
Sex:
MALE -
Eligible Ages:
18 and up
Participation Criteria
Inclusion Criteria:
1. Patients undergoing standard of care robotic radical prostatectomy for high-risk localized prostate cancer as defined by any of:
1. Gleason grade ≥8
2. PSA ≥20
3. \>pT2 on preoperative MRI imaging
2. Patients must have preoperative erectile function with a baseline IIEF score of ≥17
Exclusion Criteria:
1. Patients with previous pelvic surgery
2. Patients with previous pelvic radiotherapy
3. Patient with previous focal therapy for prostate cancer
4. Patients aged \< 18 years at diagnosis
5. Legally incapable patients
6. Patients who are unable to complete questionnaires and have no companion to help complete them
7. Patients undergoing a concomitant cancer surgery
8. Patients with pre-existing neurologic disease
Study Location
Jewish General Hospital, CIUSSS Centre-Ouest de l'île de Montréal
Jewish General Hospital, CIUSSS Centre-Ouest de l'île de MontréalMontreal, Quebec
Canada
Contact Study Team
Jewish General Hospital
Jewish General HospitalMontréal, Quebec
Canada
Contact Study Team
- Study Sponsored By
- Sir Mortimer B. Davis - Jewish General Hospital
- Participants Required
- More Information
- Study ID:
NCT06521710